Baculoviruses and Mammalian Cell-based Assays for Drug Screening

Advances in Virus Research

Volumn 68, Issue , 2006, Pages 255-286

  Condreay, J Patrick ^a   Ames, Robert S ^a   Hassan, Namir J ^b   Kost, Thomas A ^a   Merrihew, Raymond V ^a   Mossakowska, Danuta E ^b   Pountney, David J ^b   Romanos, Michael A ^c  

^a GLAXOSMITHKLINE   (United States)

^b Department of Screening and Compound Profiling GlaxoSmithKline Discovery Research ^*  (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; G PROTEIN COUPLED RECEPTOR; ION CHANNEL; NEUROTRANSMITTER TRANSPORTER; RECOMBINANT PROTEIN; STEROID RECEPTOR;

ANIMAL; BACULOVIRUS; BIOSYNTHESIS; DRUG SCREENING; GENE TRANSFER; GENETICS; HUMAN; METHODOLOGY; REVIEW;

ANIMALS; BACULOVIRIDAE; DRUG EVALUATION, PRECLINICAL; GENE TRANSFER TECHNIQUES; HUMANS; ION CHANNELS; NEUROTRANSMITTER TRANSPORT PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, STEROID; RECOMBINANT PROTEINS;

EID: 33748745027     PISSN: 00653527     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-3527(06)68007-X     Document Type: Review

References (104)

1. Abdelhamed A.M., Kelley C.M., Miller T.G., Furman P.A., and Isom H.C. Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment. J. Virol. 76 (2002) 8148-8160
2. Abdelhamed A.M., Kelley C.M., Miller T.G., Furman P.A., Cable E.E., and Isom H.C. Comparison of anti-hepatitis B virus activities of lamivudine and clevudine by a quantitative assay. Antimicrob. Agents Chemother. 47 (2003) 324-336
3. Ames R.A., Nuthulaganthi P., Fornwald J.A., Shabon U., van-der-Keyl H.K., and Elshourbagy N.A. Heterologous expression of G protein-coupled receptors in U-2 OS osteosarcoma cells. Receptors Channels 10 (2004) 117-124
4. Ames R.S., Fornwald J.A., Nuthulaganthi P., Trill J.J., Foley J.J., Buckley P.T., Kost T.A., Wu Z., and Romanos M.A. BacMam recombinant baculoviruses in G protein-coupled receptor drug discovery. Receptors Channels 10 (2004) 99-107
5. Angus P., Vaughan R., Xiong S., Delaney W., Gibbs C., Brosgart C., Colledge D., Edwards R., Ayres A., Barthlomeusz A., and Locarnini S. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology 125 (2003) 292-297
6. Ashcroft F.M. "Ion Channels and Disease: Channelopathies." (2000), Academic Press, San Diego
7. Ayrton A., and Morgan P. Role of transport proteins in drug absorption distribution and excretion. Xenobiotica 31 (2001) 469-497
8. Barsoum J., Brown R., McKee M., and Boyce F.M. Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum. Gene Ther. 8 (1997) 2011-2018
9. Bass A.S., Tomaselli G., Bullingham III R., and Kinter L.B. Drug effects on ventricular repolarization: A critical evaluation of the strengths and weaknesses of current methodologies and regulatory practices. J. Pharmacol. Toxicol. Methods 52 (2005) 12-21
10. Beato M., Candau R., Chavez S., Mows C., and Truss M. Interaction of steroid hormone receptors with transcription factors involves chromatin remodelling. J. Steroid Biochem. 56 (1996) 47-59
11. Behm D.J., Stankus G., Doe C.P.A., Willette R.N., Sarau H.M., Foley J.J., Schmidt D.B., Nuthulaganti P., Fornwald J.A., Ames R.S., Lambert D.G., Calo G., et al. The peptidic urotensin-II (UT) ligand GSK248451 possesses less intrinsic activity than the low efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems. Br. J. Pharmacol. 148 (2006) 173-190
12. Black B.C., Brennan L.A., Dierks P.M., and Gard I.E. Commercialization of baculoviral insecticides. In: Miller L.K. (Ed). "The Baculoviruses" (1997), Plenum Press, New York 341-387
13. Boudjelal M., Mason S.J., Katso R.M., Fleming J.M., Parham J.H., Condreay J.P., Merrihew R.V., and Cairns W. The application of BacMam technology in nuclear receptor drug discovery. Biotechnol. Ann. Rev. 11 (2005) 101-125
14. Boutell C., Canning M., Orr A., and Everett R.D. Reciprocal activities between herpes simplex virus type 1 regulatory protein ICP0, a ubiquitin E3 ligase, and ubiquitin-specific protease USP7. J. Virol. 79 (2005) 12342-12354
15. Boyce F.M., and Bucher N.L.R. Baculovirus-mediated gene transfer into mammalian cells. Proc. Natl. Acad. Sci. USA 93 (1996) 2348-2352
16. Carbonell L.F., and Miller L.K. Baculovirus interaction with non-target organisms: A virus-borne reporter gene is not expressed in two mammalian cell lines. Appl. Environ. Microbiol. 53 (1987) 1412-1417
17. Carbonell L.F., Klowden M.J., and Miller L.K. Baculovirus-mediated expression of bacterial genes in dipteran and mammalian cells. J. Virol. 56 (1985) 153-160
18. Cersosimo R.J. Tamoxifen for prevention of breast cancer. Ann. Pharmacother. 37 (2003) 268-273
19. Chan L.M.S., Lowes S., and Hirst B.H. The ABCs of drug transport in intestine and liver: Efflux proteins limiting drug absorption and bioavailability. Eur. J. Pharm. Sci. 21 (2004) 25-51
20. Chen R.Y., Edwards R., Shaw T., Colledge D., Delaney IV W.E., Isom H., Bowden S., Desmond P., and Locarnini S.A. Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine-resistant HBV in vitro. Hepatology 37 (2003) 27-35
21. Cheshenko N., Krougliak N., Eisensmith R.C., and Krougliak V.A. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus. Gene Ther. 8 (2001) 846-854
22. Clare J.J. Functional expression of ion channels in mammalian systems. In: Clare J.J., and Trezise D.J. (Eds). "Expression and Analysis of Recombinant Ion Channels" (2006), Wiley-VCH, Weinheim 79-109
23. Clay W.C., Condreay J.P., Moore L.B., Weaver S.L., Watson M.A., Kost T.A., and Lorenz J.J. Recombinant baculoviruses used to study estrogen receptor function in human osteosarcoma cells. Assay Drug Dev. Technol. 1 (2003) 801-810
24. Condreay J.P., and Kost T.A. Virus-based vectors for gene expression in mammalian cells: Baculovirus. In: Makrides S.C. (Ed). "Gene Transfer and Expression in Mammalian Cells" (2003), Elsevier Science, Amsterdam 137-149
25. Condreay J.P., Witherspoon S.M., Clay W.C., and Kost T.A. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc. Natl. Acad. Sci. USA 96 (1999) 127-132
26. Delaney IV W.E., and Isom H.C. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus. Hepatology 28 (1998) 1134-1146
27. Delaney IV W.E., Miller T.G., and Isom H.C. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2′,3′-dideoxy-3′-thiacytidine on replication of hepatitis B virus and accumulation of closed circular DNA. Antimicrob. Agents Chemother. 43 (1999) 2017-2026
28. Delaney IV W.E., Edwards R., Colledge D., Shaw T., Torresi J., Miller T.G., Isom H.C., Bock C.T., Manns M.P., Trautwein C., and Locarnini S. Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus. Antimicrob. Agents Chemother. 45 (2001) 1705-1713
29. Doller G., Groner A., and Straub O.C. Safety evaluation of nuclear polyhedrosis virus replication in pigs. Appl. Environ. Microbiol. 45 (1983) 1229-1233
30. Drews J. Drug discovery: A historical perspective. Science 287 (2000) 1960-1964
31. Duisit G., Saleun S., Douthe S., Barsoum J., Chadeuf G., and Moullier P. Baculovirus vector requires electrostatic interactions including heparan sulfate for efficient gene transfer in mammalian cells. J. Gen. Med. 1 (1999) 93-102
32. Dwarakanath R.S., Clark C.L., McElroy A.K., and Spector D.H. The use of recombinant baculoviruses for sustained expression of human cytomegalovirus immediate early proteins in fibroblasts. Virology 284 (2001) 297-307
33. Fipaldini C., Bellei B., and LaMonica N. Expression of hepatitis C virus cDNA in a human hepatoma cell line mediated by a hybrid baculovirus-HCV vector. Virology 255 (1999) 302-311
34. Fujita R., Matsuyama T., Yamagishi J., Sahara K., Asano S., and Bando H. Expression of Autographa californica multiple nucleopolyhedrovirus genes in mammalian cells and upregulation of the host β-actin gene. J. Virol. 80 (2006) 2390-2395
35. Gaillard R.K., Barnard J., Lopez V., Hodges P., Bourne E., Johnson L., Allen M.I., Condreay P., Miller W.H., and Condreay L.D. Kinetic analysis of wild-type and YMDD mutant hepatitis B virus polymerases and effects of deoxyribonucleotide concentrations on polymerase activity. Antimicrob. Agents Chemother. 46 (2002) 1005-1013
36. Galperin M.Y. The molecular biology database collection: 2004 update. Nucl. Acids Res. 32 (2004) D3-D22 (database Issue):
37. Gonzalez M.I., and Robinson M.B. Neurotransmitter transporters: Why dance with so many partners?. Curr. Opin. Pharmacol. 4 (2004) 30-35
38. Griffith J.K., and Sansom C.E. "The Transporter Facts Book." (1998), Academic Press, San Diego
39. Hacker D.L., Derow E., and Wurm F.M. The CELO adenovirus Gam1 protein enhances transient and stable recombinant protein expression in Chinese hamster ovary cells. J. Biotechnol. 117 (2005) 21-29
40. Hartig P.C., Cardon M.C., and Kawanishi C.Y. Effect of baculovirus on selected vertebrate cells. Dev. Biol. Stand. 76 (1992) 313-317
41. Hassan N.J., Pountney D.J., Ellis C., and Mossakowska D. BacMam recombinant baculovirus in transporter expression: A study of BCRP and OATP1B1. Protein Expr. Purif. 47 (2006) 591-598
42. Hofmann C., Sandig V., Jennings G., Rudolph M., Schlag P., and Strauss M. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc. Natl. Acad. Sci. USA 92 (1995) 10099-10103
43. Hofmann C., Lehnert W., and Strauss M. The baculovirus vector system for gene delivery into hepatocytes. Gene Ther. Mol. Biol. 1 (1998) 231-239
44. Hopkins A.L., and Groom C.R. The druggable genome. Nat. Rev. Drug Discov. 1 (2002) 727-730
45. Horrocks C., Halse R., Suzuki R., and Shepherd P.R. Human cell systems for drug discovery. Curr. Opin. Drug Discov. Devel. 6 (2003) 570-575
46. Hsu C.S., Ho Y.C., Wang K.C., and Hu Y.C. Investigation of optimal transduction conditions for baculovirus-mediated gene delivery into mammalian cells. Biotechnol. Bioeng. 88 (2004) 42-51
47. Hu Y.C., Tsai T.C., Chang Y.J., and Huang J.H. Enhancement and prolongation of baculovirus-mediated expression in mammalian cells: Focuses on strategic infection and feeding. Biotechnol. Prog. 19 (2003) 373-379
48. Isom H.C., Abdelhamed A.M., Bilello J.P., and Miller T.G. Baculovirus-mediated gene transfer for the study of hepatitis B virus. Methods Mol. Biol. 96 (2004) 219-237
49. Jarvis D.L. Baculovirus expression vectors. In: Miller L.K. (Ed). "The Baculoviruses" (1997), Plenum Press, New York 389-431
50. Jarvis D.L., and Garcia A. Long-term stability of baculoviruses stored under various conditions. Biotechniques 16 (1994) 508-513
51. Jenkinson S., McCoy D.C., Kerner S.A., Ferris R.G., Lawrence W.K., Clay W.C., Condreay J.P., and Smith C.D. Development of a novel high-throughput surrogate assay to measure HIV envelope/CCR5/CD4-mediated viral/cell fusion using BacMam baculovirus technology. J. Biomol. Screen. 8 (2003) 463-470
52. Jorio H., Tran R., and Kamen A. Stability of serum-free and purified baculovirus stocks under various storage conditions. Biotechnol. Prog. 22 (2006) 319-325
53. Katso R.M., Parham J.H., Caivano M., Clay W.C., Condreay J.P., Gray D.W., Lindley K.M., Mason S.J., Rieger J., Wakes N.C., Cairns W.J., and Merrihew R.V. Evaluation of cell-based assays for steroid nuclear receptors delivered by recombinant baculoviruses. J. Biomol. Screen. 10 (2005) 715-724
54. Kohlbrenner E., Aslanidi G., Nash K., Shklyaev S., Campbell-Thompson M., Byrne B.J., Snyder R.O., Muzyczka N., Warrington Jr. K.H., and Zolotukhin S. Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system. Mol. Ther. 12 (2005) 1217-1225
55. Kost T.A., and Condreay J.P. Recombinant baculoviruses as mammalian cell gene-delivery vectors. Trends Biotechnol. 20 (2002) 173-180
56. Kost T.A., Condreay J.P., and Jarvis D.L. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat. Biotechnol. 23 (2005) 567-575
57. Kost T.A., Condreay J.P., and Mickleson C.A. Biosafety and viral gene transfer vectors. In: Fleming D.O., and Hunt D.L. (Eds). "Biological Safety: Principles and Practices". 4th Ed. (2006), ASM Press, Washington, DC 509-529
58. Kraus W.L., and Wong J. Nuclear receptor-dependent transcription with chromatin. Is it all about enzymes?. Eur. J. Biochem. 269 (2002) 2275-2283
59. Kronschnabi M., and Stamminger T. Synergistic induction of intercellular adhesion molecule-1 by the human cytomegalovirus transactivators IE2p86 and pp71 is mediated via an Sp-1 binding site. J. Gen. Virol. 84 (2003) 61-73
60. Kukkonen S.P., Airenne K.J., Marjomäki V., Laitinen O.H., Lehtolainen P., Kankaanpää P., Mähönen A.J., Räty J.K., Nordlund H.R., Oker-Blom C., Kulomaa M.S., and Ylä-Herttuala S. Baculovirus capsid display: A novel tool for transduction imaging. Mol. Ther. 8 (2003) 853-862
61. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., and Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270 (1995) 12953-12956
62. Lu L., Ho Y., and Kwang J. Surpression of porcine arterivirus replication by baculovirus-delivered shRNA targeting nucleoprotein. Biochem. Biophys. Res. Commun. 340 (2006) 1178-1183
63. Magga J., Bart G., Oker-Blom C., Kukkonen J.P., Akerman K.E., and Nasman J. Agonist potency differentiates G protein activation and Ca(2+) signalling by the orexin receptor type 1. Biochem. Pharmacol. 71 6 (2006) 827-836
64. Mannix C., and Jarman R.F. A guide to successful scale-up of the baculovirus expression system. In: Al-Rubeai M. (Ed). "Cell Engineering, Vol. 2: Transient Expression" (2000), Kluwer Academic Publishers, Dordrecht 43-55
65. Matsuo E., Tani H., Lim C.K., Komoda Y., Okamoto T., Miyamoto H., Moriishi K., Yagi S., Patel A.H., Miyamura T., and Matsuura Y. Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus. Biochem. Biophys. Res. Commun. 340 (2006) 200-208
66. McCormick C.J., Rowlands D.J., and Harris M. Efficient delivery and regulable expression of hepatitis C virus full-length and minigenome constructs in hepatocyte-derived cell lines using baculovirus vectors. J. Gen. Virol. 83 (2002) 383-394
67. McCormick C.J., Challinor L., MacDonald A., Rowlands D.J., and Harris M. Introduction of replication-competent hepatitis C virus transcripts using a tetracycline-regulable baculovirus delivery system. J. Gen. Virol. 85 (2004) 429-439
68. McDonnell D.P., Vegeto E., and Gleeson M.A. Nuclear hormone receptors as targets for new drug discovery. Biotechnology 11 (1993) 1256-1261
69. Meghrous J., Aucoin M.G., Jacob D., Chahal P.S., Arcand N., and Kamen A.A. Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: From shake flasks to a 20 L bioreactor. Biotechnol. Prog. 21 (2005) 154-160
70. Meier C.A. Regulation of gene expression by nuclear hormone receptors. J. Recept. Signal Transduct. Res. 17 (1997) 319-335
71. Merrihew R.V., Clay W.C., Condreay J.P., Witherspoon S.M., Dallas W.S., and Kost T.A. Chromosomal integration of transduced recombinant baculovirus DNA in mammalian cells. J. Virol. 75 (2001) 903-909
72. Merrihew R.V., Kost T.A., and Condreay J.P. Baculovirus-mediated gene delivery into mammalian cells. Method. Mol. Biol. 246 (2004) 355-365
73. Mizuno N., Niwa T., Yotsumoto Y., and Sugiyama Y. Impact of drug transporter studies on drug discovery and development. Pharmacol. Rev. 55 (2003) 425-461
74. Nicholson L.J., Philippe M., Paine A.J., Mann D.A., and Dolphin C.T. RNA interference mediated in human primary cells via recombinant baculoviral vectors. Mol. Ther. 11 (2005) 638-644
75. Ong S.T., Li. F., Du J., Tan Y.W., and Wang S. Hybrid cytomegalovirus enhancer-h1 promoter-based plasmid baculovirus vectors mediate effective RNA interference. Hum. Gene Ther. 16 (2005) 1404-1412
76. ATP channel expression in mammalian cells utilizing recombinant baculovirus transduction. Receptors Channels 8 (2002) 99-111
77. s3 protein kinase that exhibits altered functions. J. Virol. 79 (2005) 8470-8479
78. Pritchard J.B., and Miller D.S. Expression systems for cloned xenobiotic transporters. Toxicol. App. Pharmacol. 204 (2005) 256-262
79. Ramos L., Kopec L.A., Sweitzer S.M., Fornwald J.A., Zhao H., McAllister P., McNulty D.E., Trill J.J., and Kane J.F. Rapid expression of recombinant proteins in modified CHO cells using the baculovirus system. Cytotechnology 38 (2002) 37-41
80. Schroeder K.S., and Neagle B.D. FLIPR: A new instrument for accurate, high throughput optical screening. J. Biomol. Screen. 1 (1996) 75-80
81. Sells M.A., Chen M.L., and Acs G. Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 84 (1987) 1005-1009
82. Shoji I., Aizaki H., Tani H., Ishii K., Chiba T., Saito I., Miyamura T., and Matsuura Y. Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors. J. Gen. Virol. 78 (1997) 2657-2664
83. Song S.U., and Boyce F.M. Combination treatment for osteosarcoma with baculoviral vector mediated gene therapy (p53) and chemotherapy (adriamycin). Exp. Mol. Med. 33 (2001) 46-53
84. Song S.U., Shin S.H., Kim S.K., Choi G.S., Kim W.C., Lee M.H., Kim S.J., Kim I.H., Choi M.S., Hong W.J., and Lee K.H. Effective transduction of osteogenic sarcoma cells by a baculovirus vector. J. Gen. Virol. 84 (2003) 697-703
85. Soudijn W., and van Wijngaarden I. The GABA transporter and its inhibitors. Curr. Med. Chem. 7 (2000) 1063-1079
86. Spenger A., Ernst W., Condreay J.P., Kost T.A., and Grabherr R. Influence of promoter choice and trichostatin A treatment on expression of baculovirus delivered genes in mammalian cells. Prot. Expr. Purif. 38 (2004) 17-23
87. Szewczyk B., Hoyos-Carvajal L., Paluszek M., Skrzecz I., and Lobo de Souza M. Baculoviruses-re-emerging biopesticides. Biotechnol. Adv. 24 (2006) 143-160
88. Tani H., Nishijima M., Ushijima H., Miyamura T., and Matsuura Y. Characterization of cell-surface determinants important for baculovirus infection. Virology 279 (2001) 343-353
89. Tate C.G., Haase J., Baker C., Boorsma M., Magnani F., Vallis Y., and Williams D.C. Comparison of seven different heterologous protein expression systems for the production of serotonin transporter. Biochim. Biophysica Acta 1610 (2003) 141-153
90. Tjia S.T., zu Altenschildesche G.M., and Doerfler W. Autographa californica polyhedrosis virus (AcNPV) DNA does not persist in mass cultures of mammalian cells. Virology 125 (1983) 107-117
91. Urabe M., Ding C., and Kotin R.M. Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum. Gene Ther. 13 (2002) 1935-1943
92. Urabe M., Nakakura T., Xin K.Q., Obara Y., Mizukami H., Kume A., Kotin R.M., and Ozawa K. Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells. J. Virol. 80 (2006) 1874-1885
93. van Loo N., Fortunati E., Ehlert E., Rabelink M., Grosveld F., and Scholte B.J. Baculovirus infection of nondividing mammalian cells: Mechanisms of entry and nuclear transport of capsids. J. Virol. 75 (2001) 961-970
94. Ververeli K., and Chipps B. Oral corticosteroid-sparing effects of inhaled corticosteroids in the treatment of persistent and acute asthma. Ann. Allerg. Asthma Im. 92 (2004) 512-522
95. Volkman L.E., and Goldsmith P.A. In vitro survey of Autographa californica nuclear polyhedrosis virus interaction with nontarget vertebrate host cells. Appl. Environ. Microbiol. 45 (1983) 1085-1093
96. Wellington K. Rosiglitazone/metformin. Drugs 65 (2005) 1581-1592
97. Whitfield G.K., Jurutka P.W., Haussler C.A., and Haussler M.R. Steroid hormone receptors: Evolution, ligands, and molecular basis of biologic function. J. Cell. Biochem. 32-33 Suppl. (1999) 110-122
98. Wieczorke R., Dlugai S., Krampe S., and Boles E. Characterisation of mammalian GLUT glucose transporters in a heterologous yeast expression system. Cell Physiol. Biochem. 13 (2003) 123-134
99. Xia C.Q., Yang J.J., and Gan L.-S. Breast cancer resistance protein in pharmacokinetics and drug-drug interactions. Expert Opin. Drug Metab. Toxicol. 1 (2005) 595-611
100. Zeisel M.B., and Baumert T.F. Production of infectious hepatitis C virus in tissue culture: A breakthrough for basic and applied research. J. Hepatology 44 (2006) 436-439
101. Zhang J.H., Chung T.D., and Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4 (1999) 67-73
102. Zhang Z., Protzer U., Hu Z., Jacob J., and Liang T.J. Inhibition of cellular proteosome activities enhances hepadnavirus replication in an HBX-independent manner. J. Virol. 78 (2004) 4566-4572
103. Zheng W., Spencer R.H., and Kiss L. High throughput assay technologies for ion channel drug discovery. Assay Drug Dev. Technol. 2 (2004) 543-552
104. Zhou G., and Roizman B. Truncated forms of glycoprotein D of herpes simplex virus 1 capable of blocking apoptosis and of low-efficiency entry into cells form a heterodimer dependent on the presence of a cysteine located in the shared transmembrane domains. J. Virol. 76 (2002) 11469-11475